far
away
import
pulmonari
diseas
human
relat
smoke
tobacco
howev
occup
lung
diseas
caus
inhal
industri
chemic
particul
matter
antigen
also
import
caus
morbid
mortal
reason
consider
effort
direct
examin
airborn
pollut
recent
year
includ
studi
effect
laboratori
anim
administ
inhal
rout
extens
studi
shown
complex
array
defens
mechan
protect
lung
advers
effect
airborn
substanc
pathogen
organ
aerodynam
factor
prevent
access
particl
larger
diamet
deposit
wall
nasal
passag
particl
measur
im
diamet
tend
trap
mucuscov
ciliat
epithelium
line
bronchial
tree
remov
mucociliari
transport
aid
cough
reflex
smaller
particl
may
reach
alveoli
ingest
transport
pulmonari
macrophag
consider
airborn
deliveri
lung
also
import
develop
therapi
administ
via
respiratori
tract
whilst
inhal
rout
use
mani
year
volatil
anaesthet
gase
respiratori
tract
increasingli
employ
deliveri
therapi
asthma
lung
diseas
also
mean
system
deliveri
polypeptid
insulin
contrast
advers
pulmonari
effect
cigarett
smoke
industri
pollut
therapeut
agent
remain
rel
minor
caus
pulmonari
toxic
human
although
actual
incid
difficult
ascertain
howev
druginduc
pulmonari
diseas
appear
increasingli
frequent
clinic
problem
drug
associ
parenchym
pulmonari
injuri
human
continu
increas
although
difficult
assess
context
underli
diseas
process
suggest
patient
receiv
wellestablish
anticanc
drug
develop
variou
form
pulmonari
toxic
novel
antineoplast
therapi
may
similar
liabil
druginduc
toxic
usual
occur
exposur
lung
tissu
via
circul
parent
drug
metabolit
although
increasingli
advers
effect
direct
administr
drug
lung
need
consider
preclin
studi
patient
number
drug
associ
pulmonari
toxic
occur
differ
mechan
take
differ
form
specif
pharmacolog
action
drug
produc
excess
effect
bronchial
calibr
pulmonari
function
drug
mediat
allerg
reaction
bronchi
lung
may
also
produc
varieti
obscur
diffus
pulmonari
alveolar
condit
includ
pulmonari
syndrom
resembl
system
lupu
respiratori
tract
major
rout
microorgan
gain
entri
bodi
opportunist
pulmonari
infect
bacteria
virus
fungi
protozoa
consequ
immunosuppress
broadspectrum
antibacteri
therapi
organ
drug
disturb
coagul
may
precipit
pulmonari
thromboembol
haemorrhag
local
lung
lesion
also
result
accident
diagnost
therapeut
inhal
xenobiot
mucociliari
clearanc
also
sensit
therapeut
agent
affect
secret
mucu
fluid
ciliari
activ
transport
treatment
antacid
histamin
blocker
also
increas
risk
pneumonia
develop
patient
intens
care
unit
increas
gastric
ph
lead
overgrowth
gramneg
bacteria
stomach
retrograd
pharyng
colon
preclin
safeti
studi
patholog
respiratori
system
result
intercurr
diseas
induc
drug
administ
system
intranas
inhal
mode
therapi
pose
particular
challeng
term
formul
technolog
requir
administ
drug
differ
anatom
physiolog
characterist
airway
also
influenc
drug
toxic
disposit
metabol
develop
drug
administ
inhal
intranas
rout
particularli
difficult
perceiv
risk
high
local
drug
concentr
respiratori
tissu
use
potenti
vulner
patient
pulmonari
diseas
complex
technolog
develop
support
assess
advers
effect
inhal
substanc
rodent
nonrod
speci
extrapol
experiment
find
human
order
administ
drug
inhal
necessari
gener
aerosol
suspens
particl
ga
welldefin
composit
particl
size
shape
must
deliv
respiratori
tract
laboratori
anim
way
parallel
like
human
exposur
case
therapeut
agent
avoid
nonrespiratori
pathway
skin
food
aerosol
inhal
variou
fraction
particl
deposit
differ
locat
respiratori
tract
site
deposit
depend
primarili
particl
size
variabl
site
deposit
occur
among
differ
laboratori
anim
speci
human
virtu
differ
size
shape
respiratori
passag
well
breath
pattern
addit
differ
type
inhal
use
human
therapi
consid
assess
deliv
differ
materi
lung
exampl
nebul
propellantdriven
meter
dose
inhal
dri
powder
inhal
asthma
treatment
subsequ
fate
inhal
particl
depend
size
also
shape
chemic
natur
solubl
bodi
fluid
solubl
substanc
absorb
blood
stream
remov
pulmonari
circul
may
also
undergo
metabol
enzym
present
cell
popul
respiratori
tract
reactiv
metabolit
may
caus
local
pulmonari
damag
insolubl
inert
particl
remov
primarili
mucociliari
transport
system
trachea
bronchi
phagocytosi
macrophag
overload
lung
even
rel
inert
nonfibr
particl
titanium
dioxid
carbon
black
may
impair
alveolar
macrophagemedi
particl
clearanc
may
lead
turn
accumul
dust
time
eventu
fibrot
tumorigen
respons
particularli
rat
measur
respir
rate
tidal
volum
airway
resist
pulmonari
ga
exchang
disposit
inhal
substanc
import
place
evalu
chemic
induc
lung
damag
laboratori
anim
howev
key
compon
evalu
advers
effect
inhal
substanc
care
morpholog
assess
fix
tissu
even
though
novel
sensit
physiolog
method
character
oedema
follow
lung
injuri
rodent
light
electron
microscopi
lung
tissu
provid
vital
qualit
evid
natur
injuri
nasal
chamber
structur
first
subject
effect
inhal
substanc
whether
microorgan
chemic
substanc
although
chamber
usual
examin
great
detail
convent
toxic
studi
substanc
administ
oral
parenter
rout
care
examin
histolog
drug
administ
inhal
studi
nasopharyng
silicon
rubber
cast
shown
consider
speci
differ
anatomi
part
airway
rel
total
nasal
length
nasopharynx
longest
rat
shortest
human
dog
intermedi
posit
maxilloturbin
rel
simpl
structur
man
nonhuman
primat
highli
complex
dog
rodent
consequ
region
nasal
airflow
disposit
pattern
vari
consider
influenc
distribut
lesion
produc
inhal
xenobiot
nasal
caviti
howev
comparison
nasal
caviti
rhesu
monkey
human
use
magnet
reson
imag
nasal
cast
shown
mani
similar
structur
exist
speci
anterior
nare
line
stratifi
squamou
epithelium
zone
sinus
cover
either
respiratori
olfactori
epithelium
zone
transit
epithelium
junction
two
type
respiratori
epithelium
similar
found
elsewher
respiratori
passag
compos
ciliat
cell
serou
mucou
cell
brush
cell
intermedi
cell
progenitor
basal
cell
repres
cellular
system
engag
mucociliari
clearanc
carri
surfac
secret
nasopharynx
clear
swallow
although
epithelium
similar
line
larg
airway
key
differ
particularli
rich
complement
secretori
cell
complex
vasculatur
nose
modul
capillari
arteri
venou
blood
flow
mucosa
mucin
may
particularli
import
postul
physic
protect
function
also
possess
antioxid
properti
virtu
scaveng
behaviour
high
proport
sugar
group
proport
nose
line
olfactori
mucosa
variabl
speci
dispos
much
larger
area
dog
rodent
primat
howev
structur
similar
human
rodent
locat
dorsal
posterior
region
nasal
passag
direct
line
airflow
normal
respir
olfactori
mucosa
pseudostratifi
columnar
epithelium
compos
basal
cell
sustentacular
cell
sensori
cell
mucussecret
bowman
gland
situat
lamina
propria
basal
cell
compos
two
distinct
type
light
dark
cell
light
type
repres
primit
stem
cell
popul
sustentacular
support
cell
noncili
columnar
cell
possess
microvilli
extend
overli
layer
mucu
cell
bodi
olfactori
sensori
neuron
situat
middl
layer
epithelium
sustentacular
basal
cell
dendrit
process
extend
epitheli
surfac
end
ciliat
expans
refer
olfactori
vesicl
believ
receptor
odour
percept
olfactori
axon
extend
cell
bodi
penetr
basement
membran
bundl
becom
surround
schwann
cell
eventu
join
olfactori
bulb
olfactori
system
import
toxicolog
select
damag
xenobiot
includ
therapeut
agent
presum
result
high
metabol
capac
superfici
locat
neural
cell
olfactori
epithelium
also
provid
model
system
studi
effect
xenobiot
neural
cell
submucos
mucou
gland
well
character
rat
hamster
dog
divid
later
nasal
gland
maxillari
recess
gland
situat
posterior
part
nasal
caviti
compos
mucussecret
cell
immunocytochem
studi
use
antisera
rais
major
isoenzym
rat
hepat
microsom
cytochrom
induc
phenobarbiton
well
nadphcytochrom
reductas
epoxid
hydrolas
glutathion
stransferas
b
c
e
shown
presenc
rat
nasal
mucos
cell
enzym
appear
express
high
level
respiratori
tract
mucosa
suggest
nasal
mucosa
capac
metabol
activ
xenobiot
oxid
also
hydrat
inactiv
potenti
toxic
epoxid
conjug
electrophil
reactiv
metabolit
reduc
glutathion
shown
distribut
immunereact
enzym
differ
olfactori
respiratori
mucosa
xenobiot
metabol
within
olfactori
respiratori
mucosa
olfactori
region
appear
possess
greatest
capabl
oxid
metabol
consequ
region
differ
nasal
toxic
tumour
format
inhal
materi
may
respons
differ
water
solubl
deposit
pattern
also
differ
format
reactiv
metabolit
anoth
featur
metabol
activ
induc
system
administ
xenobiot
alter
distribut
enzym
activ
nasal
mucosa
studi
mous
olfactori
mucosa
shown
whilst
typic
hepat
induc
significantli
chang
express
mucosa
olfactori
toxic
alter
pattern
enzym
distribut
like
mani
tissu
expos
extern
environment
agent
nasal
mucosa
possess
aggreg
lymphoid
tissu
underli
lamina
propria
rat
area
character
follicl
contain
b
cell
area
locat
ventral
aspect
later
wall
nasal
airway
open
nasopharyng
duct
like
gutassoci
lymphoid
tissu
nasal
follicl
shown
rat
cover
special
epithelium
island
cell
microvilli
socal
membran
cell
littl
known
toxic
occur
tissu
despit
strateg
posit
respiratori
tract
rodent
rel
small
size
nose
nasal
sinus
facilit
histolog
examin
usual
area
section
transvers
sever
standard
block
follow
decalcif
number
detail
public
describ
histolog
prepar
assess
record
patholog
rodent
nasal
caviti
care
standard
histolog
section
care
record
lesion
use
diagram
rodent
nasal
caviti
use
assess
lesion
nasal
caviti
found
inhal
studi
larger
speci
particularli
dog
primat
section
block
complex
although
dissect
requir
similar
procedur
follow
decalcif
adopt
care
examin
haematoxylin
eosin
stain
section
remain
paramount
assess
nasal
caviti
although
special
stain
may
help
examin
cytokeratin
express
respiratori
mucosa
use
marker
epitheli
differenti
respiratori
tract
test
system
relat
innerv
nasal
mucosa
propos
alari
trigemin
nerv
end
nasal
mucosa
mice
mediat
respons
sensori
irrit
measur
decreas
respiratori
rate
shown
good
correl
exist
decreas
respir
rate
mice
expos
airborn
chemic
nasal
irrit
potenti
chemic
human
enabl
detect
airborn
sensori
irrit
predict
accept
level
exposur
upper
respiratori
tract
peopl
microbi
pathogen
infecti
agent
caus
inflamm
nose
nasal
sinus
may
associ
inflamm
conjunctiva
middl
ear
oral
caviti
murin
pathogen
may
caus
alter
respiratori
tract
confound
assess
chang
induc
xenobiot
rat
microbiolog
agent
implic
develop
rhiniti
sinus
includ
corynebacterium
kutscheri
pseudotuberculosi
streptococcu
pneumonia
pasteurella
pneumotropica
klebsiella
pneumonia
mycoplasma
pulmoni
sialodacryoaden
viru
rat
corona
viru
rat
infect
sialodacryoaden
viru
show
inflamm
necrosi
upper
respiratori
epithelium
well
damag
salivari
lachrym
gland
sendai
viru
paramyxoviru
also
mark
tropism
respiratori
tract
includ
nasal
caviti
associ
system
effect
compromis
studi
laboratori
rodent
occasion
fungal
infect
airway
aspergillu
fumigatu
report
variabl
shown
influenc
sever
rhiniti
produc
mycoplasma
pulmoni
strain
rat
follow
hous
lewi
fischer
strain
togeth
elimin
microbi
environment
differ
shown
lewi
strain
develop
sever
rhiniti
follow
inocul
mycoplasma
pulmoni
fischer
rat
although
reason
differ
unclear
rat
expos
ammonia
common
pollut
air
laboratori
anim
cage
also
shown
develop
lesion
dorsal
meatu
dorsal
nasal
septum
promin
turbin
lesion
character
histolog
swell
mild
degener
epithelium
appear
ammonia
exposur
potenti
acut
inflammatori
respons
nasal
caviti
microbiolog
pathogen
microorgan
report
nasal
caviti
rhesu
monkey
employ
inhal
studi
nematod
genu
anatrichosoma
section
nematod
found
squamou
epithelium
nasal
vestibul
associ
acanthosi
hyperkeratosi
epithehum
multifoc
diffus
granulomat
inflamm
submucosa
administr
toxic
irrit
substanc
laboratori
anim
inhal
rout
produc
degen
inflammatori
reactiv
chang
nasal
mucosa
rang
histolog
featur
similar
found
mucos
surfac
damag
exogen
agent
whilst
therapeut
agent
administ
inhal
rout
usual
produc
sever
degen
inflammatori
respons
nasal
mucosa
least
therapeut
dose
simpl
categori
propos
hardisti
colleagu
record
degen
reactiv
lesion
follow
exposur
volatil
chemic
use
categori
suggest
degener
regener
atrophi
postdegen
respiratori
metaplasia
basal
cell
hyperplasia
inflamm
degener
usual
earliest
morpholog
chang
character
loss
sensori
sustentacular
cell
result
thinner
mucosa
bowman
gland
nerv
bundl
individu
cell
necrosi
may
seen
sever
case
regener
character
prolifer
basal
cell
associ
epithelium
lose
regular
structur
featur
postdegen
atrophi
usual
follow
sever
damag
character
loss
sensori
sustentacular
cell
respiratori
metaplasia
process
wherebi
normal
olfactori
mucosa
replac
pseudostratifi
epithelium
respiratori
type
often
cilia
basal
cell
hyperplasia
repres
longer
term
effect
prolifer
basal
cell
form
distinct
layer
cell
respiratori
epithelium
exampl
type
distribut
degen
inflammatori
condit
induc
inhal
irrit
provid
studi
swisswebst
mice
given
variou
irrit
inhal
period
hour
per
day
day
concentr
produc
decreas
respiratori
rate
alari
test
although
degre
histolog
chang
vari
differ
agent
chang
broadli
similar
type
distribut
agent
examin
produc
littl
alter
squamou
mucosa
line
anterior
part
nose
apart
mild
increas
thick
squamou
layer
princip
site
damag
shown
anterior
respiratori
epithelium
adjac
vestibul
olfactori
epithelium
dorsal
meatu
distinct
decreas
sever
posterior
region
histolog
lesion
respiratori
epithelium
rang
mild
loss
cilia
small
area
epitheli
exfoli
frank
eros
ulcer
necrosi
epithelium
underli
tissu
includ
bone
variabl
polymorphonuclear
cell
infiltr
also
found
case
earli
squamou
metaplasia
develop
free
margin
nasomaxilloturbin
chang
olfactori
epithelium
vari
focal
extens
loss
sensori
cell
associ
damag
sustentacular
cell
sever
case
complet
loss
olfactori
epithelium
occur
although
degre
histolog
chang
shown
vari
differ
agent
lesion
induc
watersolubl
chemic
tend
remain
local
anterior
part
nasal
caviti
wherea
agent
rel
low
water
solubl
produc
lung
lesion
addit
suggest
find
demonstr
power
scrub
action
nasal
caviti
water
solubl
airborn
xenobiot
inflammatori
alter
induc
nasal
caviti
rodent
treat
therapeut
agent
high
dose
inhal
significantli
irrit
substanc
make
viabl
therapi
howev
precis
relev
chang
human
therapi
inhal
rout
sometim
question
nasal
damag
limit
high
dose
associ
alter
part
respiratori
tract
case
tulobuterol
receptor
agonist
argu
nasal
inflamm
induc
rat
one
month
inhal
toxic
studi
result
particularli
high
exposur
nasal
epithelium
drug
repres
like
human
exposur
tulobuterol
inhal
littl
nasal
exposur
would
occur
ar
novel
type
iv
phosphodiesteras
inhibitor
develop
treatment
asthma
rheumatoid
arthriti
also
report
produc
degener
olfactori
epithelium
rat
neither
dog
mice
singl
repeat
oral
dose
inhal
histolog
olfactori
epithelium
show
necrosi
superflci
epitheli
layer
includ
sustentacular
sensori
cell
spare
basal
cell
layer
also
damag
bowman
gland
develop
prolif
lesion
ultim
tumour
princip
neuroectoderm
origin
follow
chronic
treatment
highli
metabol
nasal
lesion
could
inhibit
treatment
rat
metyrapon
nonspeciflc
inhibitor
cytochrom
postul
chang
result
activ
olfactori
tissu
link
pharmacolog
phosphodiesteras
activ
nasal
epitheli
degener
necrosi
also
report
rat
dog
treat
anoth
candid
antiinflammatori
drug
intranas
rout
agent
affect
olfactori
epithelium
respiratori
mucosa
suggest
metabol
import
gener
toxic
although
nasal
caviti
often
examin
histolog
great
detail
toxic
studi
conduct
drug
administ
oral
parenter
rout
damag
nasal
mucosa
induc
drug
administ
rout
one
exampl
methimazol
thioureylen
antithyroid
drug
use
clinic
practic
oral
dose
employ
abnorm
tast
smell
describ
administr
methimazol
rel
high
dose
longevan
rat
singl
oral
intraperiton
rout
shown
produc
damag
sustentacular
sensori
cell
spare
basal
cell
basement
membran
bowman
gland
also
involv
methimazol
metabol
flavincontain
monooxygenas
system
employ
model
substrat
enzym
vitro
presenc
flavincontain
monooxygenas
isoform
olfactori
mucosa
longevan
rat
suggest
reactiv
intermedi
may
respons
nasal
toxic
similar
chang
report
mice
deplet
glutathion
olfactori
mucosa
demonstr
also
suggest
format
local
reactiv
metabolit
histolog
examin
also
shown
intraven
administr
singl
dose
vincristin
mice
damag
olfactori
epithelium
vincristin
vinca
alkaloid
deriv
use
cancer
therapi
antimitot
activ
bind
tubulin
cell
death
note
olfactori
cell
day
dose
peak
cell
prolifer
day
repair
day
featur
resembl
seen
prolifer
tissu
singl
dose
antimitot
drug
risk
damag
human
olfactori
cell
agent
effect
rat
nasal
mucosa
often
remain
uncertain
understand
rel
exposur
metabol
differ
speci
better
understand
metabol
potenti
human
olfactori
mucosa
requir
particular
respons
rodent
nasal
mucosa
irrit
substanc
includ
pharmaceut
agent
format
round
eosinophil
inclus
cytoplasm
sustentacular
cell
olfactori
epithelium
lesser
extent
respiratori
glandular
epitheli
cell
inclus
pasneg
ultrastructur
examin
show
membranebound
ellipsoid
bodi
contain
homogen
electron
dens
matrix
signific
remain
uncertain
consensu
classif
varieti
prolif
nonneoplast
chang
atyp
epitheli
lesion
neoplasm
found
rat
nasal
caviti
defin
schwartz
colleagu
classif
intern
agenc
research
cancer
provid
similar
perspect
rat
mice
prolif
lesion
may
occasion
seen
untreat
rodent
carcinogen
studi
much
commonli
induc
administr
xenobiot
inhal
carcinogen
studi
spontan
nasal
tumour
uncommon
often
squamou
type
rat
wherea
mice
spontan
squamou
tumour
extrem
rare
haemangioma
respiratori
adenoma
predomin
gener
agre
categori
describ
mucou
goblet
cell
hypertrophi
hyperplasia
affect
nasal
respiratori
epithelium
character
presenc
enlarg
mucusfil
goblet
cell
form
cluster
suggest
intraepithi
gland
squamou
cell
hyperplasia
seen
stratifi
squamou
epithelium
nare
character
focal
increas
number
cell
layer
cell
may
show
atypia
irregular
enlarg
pleomorph
nuclei
nucleoli
squamou
metaplasia
occur
respiratori
epithelium
condit
chronic
damag
character
histolog
presenc
three
layer
epitheli
cell
eosinophil
cytoplasm
clear
cell
boundari
wherea
advanc
lesion
show
typic
keratin
format
intercellular
bridg
cellular
atypia
may
also
seen
character
found
respiratori
epitheli
metaplasia
olfactori
epithelium
repres
atrophi
degener
olfactori
epithelium
loss
sensori
cell
advanc
case
loss
sustentacular
cell
replac
ciliat
noncili
respiratori
epithelium
may
seen
spontan
focal
lesion
age
rat
epitheli
hyperplasia
cellular
atypia
atyp
hyperplasia
basal
cell
hyperplasia
dysplasia
term
use
embrac
prolif
lesion
respiratori
olfactori
mucosa
nasal
caviti
vari
degre
alter
differenti
atypia
perturb
growth
pattern
epithelium
chang
found
normal
regen
respons
transient
mucos
damag
adenoma
polypoid
villou
adenoma
adenomat
villou
polyp
usual
develop
anterior
part
nasal
caviti
usual
exophyt
lesion
develop
respiratori
epithelium
nasal
gland
adenoma
respiratori
epithelium
may
papillari
form
definit
well
circumscrib
minim
cellular
pleomorph
atypia
may
occasion
occur
spontan
age
rat
adenoma
nasal
gland
usual
show
acinar
pattern
squamou
cell
papilloma
develop
squamou
epithelium
nare
area
squamou
metaplasia
respiratori
olfactori
epithelium
exophyt
lesion
limit
connect
tissu
stroma
may
develop
spontan
age
rat
carcinoma
either
squamou
glandular
differenti
develop
nasal
mucosa
histolog
similar
characterist
epitheli
tissu
rare
spontan
lesion
age
laboratori
rodent
may
induc
xenobiot
administ
inhal
oral
parenter
rout
squamou
carcinoma
report
develop
small
number
untreat
fischer
rat
use
carcinogen
studi
associ
point
mutat
chra
ckra
gene
olfactori
neuroblastoma
ethesioneuroblastoma
olfactori
neuroepithelioma
olfactori
neuroepitheli
carcinoma
show
olfactori
differenti
aris
olfactori
epithelium
seem
occur
spontan
lesion
rat
mice
rare
induc
cell
arrang
lobul
solid
sheet
scanti
stroma
cell
rel
uniform
scanti
cytoplasm
round
oval
hyperchromat
nuclei
true
rosett
lumen
pseudorosett
also
seen
poorli
differenti
tumour
type
may
requir
ultrastructur
studi
diagnosi
olfactori
neuroblastoma
typic
show
presenc
electrondens
neurosecretori
granul
neurofila
axon
detail
understand
biolog
behaviour
neoplasm
laboratori
rodent
gener
term
olfactori
neuroblastoma
usual
prefer
almost
alway
invas
tumour
olfactori
carcinoma
form
gland
follicl
rosett
occasion
report
age
syrian
hamster
mesenchym
neoplasm
may
seen
nasal
caviti
particularli
exposur
potent
carcinogen
histolog
featur
similar
soft
tissu
bone
elsewher
bodi
see
chapter
mucosa
line
larynx
trachea
becom
involv
part
upper
lower
respiratori
tract
infect
instanc
rat
acut
laryng
tracheiti
shown
accompani
experiment
infect
mycoplasma
pulmoni
sialodycroaden
viru
spontan
degen
condit
tracheal
laryng
cartilag
uncertain
pathogenesi
associ
granuloma
report
fischer
rat
condit
increas
sever
incid
advanc
age
although
seen
rat
young
week
age
tracheal
cartilag
ring
may
also
show
alter
genet
engin
anim
cjeg
tag
mice
gener
defect
cartilag
develop
larynx
rodent
also
suscept
effect
inhal
substanc
notabl
tobacco
smoke
also
pharmaceut
agent
propel
view
local
natur
induc
lesion
larynx
standard
histolog
section
techniqu
propos
rat
mice
hamster
use
anatom
landmark
target
site
locat
ventral
floor
larynx
near
base
epiglotti
cranial
ventral
laryng
diverticulum
lesion
tend
occur
ventrolater
region
cover
respiratori
epithelium
inner
aspect
arytenoid
process
line
squamou
mucosa
larynx
respond
inhal
irrit
inflammatori
degen
regen
chang
manner
similar
region
respiratori
tract
includ
disrupt
epitheli
cell
inflammatori
cell
exud
infiltr
goblet
cell
hyperplasia
squamou
metaplasia
howev
chang
specif
inhal
irrit
also
occur
respons
natur
respiratori
tract
pathogen
convent
hous
rat
pseudostratifi
ciliat
noncili
mucosa
trachea
may
also
show
patholog
alter
inhal
studi
although
site
bifurc
carina
often
first
affect
consequ
carina
systemat
includ
examin
respiratori
tract
induc
lesion
nasal
passag
rang
prolif
lesion
includ
squamou
hyperplasia
mucou
cell
hyperplasia
well
papilloma
carcinoma
mesenchym
tumour
occasion
report
airway
laboratori
rodent
human
laboratori
anim
trachea
termin
bifurc
give
rise
two
main
bronchi
serv
left
right
lung
depend
speci
main
bronchi
subdivid
branch
enter
differ
lobe
variou
form
branch
recogn
bronchi
may
aris
sidebranch
parent
stem
bronchu
monopodi
parent
bronchu
divid
two
equal
daughter
bronchu
dichotom
sever
daughter
bronchi
ipolychotom
j
studi
silicon
rubber
cast
respiratori
tract
shown
bronchial
tree
human
nonhuman
primat
essenti
dichotom
contrast
monopodi
pattern
rodent
compar
long
trachea
dog
give
rise
dichotom
upper
airway
monopodi
branch
develop
peripher
within
lobe
size
lung
gener
depend
size
weight
differ
speci
auometr
studi
shown
lung
volum
alveolar
surfac
area
diffus
capac
increas
proport
bodi
weight
across
broad
rang
mammalian
speci
although
cell
size
surfac
area
appear
determin
cell
function
rather
speci
size
dog
compar
smaller
bodi
mass
higher
airway
dimens
compar
human
number
lobe
speciesdepend
human
lung
possess
upper
lower
left
lobe
upper
middl
lower
right
lobe
contrast
upper
middl
lower
left
lobe
fourth
azygo
right
lobe
rhesu
monkey
baboon
dog
three
lobe
right
left
side
rat
mice
hamster
show
cranial
middl
caudal
postcav
right
lobe
singl
left
lobe
mice
rat
superior
inferior
lobe
left
side
hamster
cell
type
line
bronchi
gener
similar
speci
major
cell
ciliat
cell
accompani
variabl
rel
smaller
proport
basal
cell
intermedi
cell
mucou
goblet
cell
serou
cell
neuroendocrin
brush
cell
addit
mucou
cell
line
adjac
bronchial
gland
unlik
tracheal
mucosa
pseudostratifi
mucosa
intrapulmonari
bronchi
nonstratifi
ciliat
cell
tall
columnar
cell
attach
basal
intermedi
cell
desmosom
junction
tight
junction
exist
adjac
special
cell
apex
cell
possess
cilia
engag
mucociliari
clearanc
superfici
cell
surfac
also
show
pronounc
glycocalyx
cytoplasm
ciliat
cell
contain
scatter
profil
rough
endoplasm
reticulum
supranuclear
golgi
numer
mitochondria
particularli
near
apex
promin
cytoskeleton
also
found
mucou
goblet
cell
typic
mucussecret
cell
repres
bronchial
mucosa
cell
popul
man
less
pathogenfre
rat
serou
cell
cylindr
pyramid
cell
contain
small
round
close
pack
serou
granul
basal
cell
compact
pyramid
cell
rest
basement
membran
believ
progenitor
stem
cell
intermedi
cell
repres
intermedi
stage
cell
differenti
mucussecret
ciliat
cell
form
cellular
basi
mucociliari
clearanc
mechan
main
conduct
airway
epithelium
cover
mucou
blanket
fairli
complet
human
rabbit
patchier
rat
mucou
layer
segreg
upper
layer
gel
phase
separ
epitheli
cell
serou
layer
sol
phase
complex
carbohydr
glycocalyx
secret
mucosubst
show
speciesrel
differ
sugar
residu
demonstr
histochem
use
labelledlectin
mucociliari
clearanc
mechan
sensit
effect
mani
therapeut
agent
particularli
alter
mucin
fluid
electrolyt
balanc
ciliari
activ
anaesthet
gase
barbitur
narcot
alcohol
depress
clearanc
function
contrast
topic
oral
parenter
administr
agonist
isoprenalin
adrenalin
produc
dosedepend
stimul
mucociliari
transport
effect
ciliari
beat
frequenc
probabl
mediat
increas
level
cyclic
adenosin
monophosph
ciuat
cell
rather
vascular
chang
although
basal
mucociliari
function
depend
normal
vagal
tone
parasympathomimet
agent
affect
mucociliari
transport
acetylcholin
cholinerg
agent
stimul
ciliari
activ
wherea
anticholinerg
drug
atropin
hyoscin
inhibit
ciliari
activ
mucociliari
transport
substanc
may
alter
deposit
inhal
particl
lung
clara
cell
noncili
bronchiolar
cell
locat
bronchiolar
epithelium
first
describ
clara
small
cylindr
shape
highli
infold
nuclei
surfac
microvilli
well
develop
golgi
abund
endoplasm
reticulum
characterist
oval
homogen
electrondens
granul
apic
cytoplasm
rat
rabbit
human
granul
pasposit
although
usual
consid
pasneg
hamster
mous
clara
cell
high
metabol
activ
contain
cytochrom
enzym
secret
varieti
protein
clara
cell
secretori
protein
major
compon
cytoplasm
granul
shown
produc
mucin
follow
antigen
challeng
laboratori
rodent
conduct
airway
termin
abruptli
noncartilagin
termin
bronchiol
open
directli
alveolar
type
airway
alveolar
duct
turn
commun
alveoli
squamou
epitheli
type
cell
form
lung
cell
line
alveolar
surfac
virtu
extrem
long
cytoplasm
extens
princip
ga
exchang
take
place
across
cell
rat
typic
thick
barrier
nm
cytoplasm
extens
type
pneumocyt
nm
basal
lamina
nm
endotheli
cell
type
cell
contain
juxtanuclear
mitochondria
long
smooth
cytoplasm
extens
contain
mani
ribosom
pinocytot
vesicl
anatom
configur
function
type
cell
render
highli
vulner
inhal
gase
particl
main
alveolar
line
cell
granular
pneumocyt
type
ii
cell
constitut
lung
cell
cover
alveolar
surfac
cell
possess
long
cytoplasm
process
typic
type
cell
show
mani
microvilli
lumin
surfac
cell
cytoplasm
contain
rough
endoplasm
reticulum
golgi
apparatu
mitochondria
characterist
oval
osmiophil
lamellar
inclus
surfact
microaggreg
phospholipid
protein
modifi
alveolar
surfac
tension
low
inflat
volum
secret
type
ii
alveolar
cell
ultrastructur
immunocytochemistri
shown
presenc
surfact
apoprotein
synthet
organel
lamellar
bodi
cell
agreement
concept
surfact
apoprotein
synthes
rough
endoplasm
reticulum
glycosyl
golgi
store
lamellar
bodi
type
ii
cell
resist
damag
effect
xenobiot
unlik
type
cell
retain
abil
undergo
mitot
divis
follow
damag
type
cell
increas
number
mitos
evid
type
ii
cell
result
appear
larg
undifferenti
epitheli
cell
ultim
differenti
type
type
ii
cell
lung
also
contain
dens
neural
network
popul
endocrinelik
cell
believ
import
lung
function
neurosecretori
cell
kultschitski
apud
cell
scatter
spars
epitheli
surfac
larynx
trachea
bronchi
bronchiol
alveoli
cell
oval
cuboid
oval
nuclei
argyrophil
cytoplasm
electron
microscop
examin
show
contain
dens
core
granul
role
neuroendocrin
cell
lung
uncertain
immunocytochem
studi
shown
contain
number
neuroendocrin
substanc
includ
neuronespecif
enolas
synaptophysin
chromogranin
varieti
peptid
similar
vasoact
intestin
peptid
bombesin
calcitonin
serotonin
leuencephalin
p
endorphin
acth
cell
line
bronchi
bronchiol
alveolar
wall
capabl
metabol
xenobiot
immunocytochem
studi
shown
presenc
immunereact
cytochrom
nadph
cytochrom
reductas
epoxid
hydroxylas
glutathion
stransferas
bronchial
epitheli
cell
ciliat
bronchiolar
cell
clara
cell
type
ii
possibl
type
pneumocyt
rat
lung
differ
cell
popul
contain
differ
amount
enzym
clara
cell
contain
greatest
concentr
phenobarbitoneinduc
isoenzym
cytochrom
nadphcytochrom
reductas
epoxid
hydrolas
studi
microsom
enzym
activ
suggest
lung
tissu
contain
fewer
isoenzym
liver
princip
form
cyplal
wherea
enzym
activ
highli
concentr
specif
cell
type
overal
microsom
enzym
activ
low
compar
liver
basi
microsom
protein
weight
import
cell
pulmonari
alveolar
macrophag
lymphocyt
lymphocyt
found
epithelium
airway
interstitium
alveoli
part
follicl
bronchial
wall
pulmonari
macrophag
form
part
specif
immun
defenc
system
lung
involv
elsewher
bodi
antigen
present
rat
mous
distinct
popul
pulmonari
macrophag
describ
base
enzym
activ
reactiv
monoclon
antibodi
monocyt
macrophag
surfac
determin
bronchu
associ
macrophag
rat
mous
acid
phosphatas
less
nonspecif
esteras
activ
popul
found
pulmonari
alveoli
interstiti
tissu
import
aspect
immun
system
bronchusassoci
lymphoid
tissu
balt
form
part
mucos
lymphoid
system
found
epithelia
morpholog
balt
use
guid
natur
degre
immun
stimulu
lung
balt
organ
way
characterist
peripher
lymphoid
organ
structur
similar
laboratori
rat
mous
rabbit
guinea
pig
well
man
size
promin
speci
straindepend
well
function
degre
antigen
stimulu
rat
balt
compos
lymphoid
aggreg
fouicl
locat
mostli
bronchu
arteri
zone
lymphocyt
situat
immedi
bronchial
epithelium
peripher
lymphoid
tissu
balt
organ
b
cell
zone
predetermin
manner
immunocytochem
stain
shown
b
lymphocyt
zone
differ
locat
one
aggreg
anoth
two
everi
three
b
cell
compar
ratio
rat
peyer
particl
ratio
may
differ
speci
quantit
observ
cell
subset
use
monoclon
antibodi
also
shown
rat
balt
normal
contain
twice
mani
thelper
tsuppressorcytotox
lymphocyt
cell
confin
one
two
discret
zone
light
scatter
cell
within
b
cell
zone
immedi
bronchial
epithelium
common
lymph
node
interdigit
cell
also
found
epithelium
balt
show
anatom
modif
compos
ciliat
noncili
cell
cover
microvilli
convent
untreat
laboratori
rat
balt
show
littl
activ
germin
centr
usual
absent
although
balt
may
promin
rat
coloni
associ
nonspecif
inflammatori
lesion
lung
one
coloni
young
wistar
rat
germin
centr
seen
balt
untreat
anim
develop
follow
administr
singl
intratrach
dose
lipopolysaccharid
cellindepend
antigen
singl
intratrach
dose
cell
depend
antigen
horseradish
peroxidas
bovin
serum
albumin
bcg
shown
produc
minor
morpholog
chang
includ
expans
zone
lymphocyt
immedi
epithelium
infiltr
bronchial
epithelium
overli
balt
lymphocyt
addit
perivascular
peribronchi
alveolar
infiltr
small
larg
lymphocyt
macrophag
observ
lung
rat
given
bcg
studi
rat
balt
follow
intratrach
challeng
horseradish
peroxidas
show
major
cell
infiltr
bronchial
epithelium
helper
posit
lymphocyt
furthermor
la
antigen
express
epitheli
cell
overli
balt
shown
increas
associ
increas
number
size
microvilli
pronounc
glycocalyx
decreas
number
size
cilia
immunocytochem
studi
balt
tissu
mice
use
monoclon
antibodi
lymphoid
macrophag
popul
demonstr
quit
similar
arrang
cell
rat
major
cell
belong
helper
posit
class
pulmonari
lymphat
system
drain
mediastin
cervic
lymph
node
although
among
rat
strain
differ
locat
lymph
node
drainag
occur
tracer
studi
fischer
rat
use
colloid
carbon
shown
lung
lymphat
drain
mainli
posterior
mediastin
lymph
node
tracheal
wall
drain
primarili
intern
jugular
posterior
cervic
node
although
varieti
fixat
embed
stain
procedur
avail
light
electron
microscop
examin
lung
tissu
substitut
initi
care
visual
inspect
lung
autopsi
uneven
collaps
lung
open
thorac
caviti
discolor
alter
textur
pleural
cut
surfac
congest
presenc
fluid
larger
airway
may
indic
structur
damag
rodent
lung
small
pulmonari
adenoma
may
detect
inspect
good
light
fresh
lung
weight
also
help
measur
lung
assess
although
passiv
vascular
engorg
significantli
affect
valu
nevertheless
studi
normal
fischer
rat
shown
exsanguin
wet
lung
weight
show
close
relationship
bodi
weight
dri
weight
lung
consist
repres
wet
weight
regardless
age
bodi
weight
increas
wet
weight
dri
weight
appear
good
index
pulmonari
oedema
variou
method
fixat
employ
although
simpl
immers
fixat
formalin
convent
light
microscopi
virtu
simplic
avoid
risk
transloc
remov
exud
airway
alveoli
mixtur
formaldehyd
paraformaldehyd
glutaraldehyd
use
initi
fixat
electron
microscopi
best
overal
appreci
lung
architectur
achiev
instil
fix
via
trachea
appropri
constant
pressur
perfus
fixat
pulmonari
arteri
less
liabl
dislodg
intraalveolar
exud
review
method
employ
routin
rodent
toxic
studi
instil
fix
via
trachea
prefer
method
laboratori
advantag
seen
outweigh
disadvantag
sampl
procedur
import
aspect
histolog
examin
bronchi
lung
particularli
larg
laboratori
anim
extent
histolog
section
convent
toxic
studi
modul
take
account
lesion
found
macroscop
examin
type
studi
natur
test
substanc
bronchi
care
sampl
allow
assess
alter
bronchial
epithelium
morphometr
analysi
repres
sensit
tool
valu
evalu
druginduc
lung
chang
requir
particularli
rigor
sampl
evalu
procedur
tier
multipl
stage
cascad
sampl
techniqu
normal
consid
appropri
morphometr
studi
involv
divid
lung
seri
homogen
compart
strata
randomli
select
sampl
examin
appropri
light
electron
microscop
techniqu
convent
special
stain
reticulin
collagen
well
pa
alcian
blue
mucin
help
characteris
lung
damag
chang
respiratori
epithelium
immunocytochemistri
enzym
cytochemistri
also
use
studi
heterogen
cell
popul
lung
xenobiot
metabol
activ
studi
enzym
cytochem
method
well
immunocytochem
techniqu
use
antisera
specif
pulmonari
monooxygenas
relat
enzym
import
structur
compon
particularli
collagen
laminin
studi
light
ultrastructur
level
immunocytochem
method
cytokeratin
immunocytochemistri
use
method
character
chang
epitheli
cell
clara
cell
local
presenc
clara
cell
secretori
protein
ciliat
cell
presenc
tubulin
endocrin
cell
visual
immunocytochemistri
use
antibodi
gener
neuroendocrin
marker
chromogranin
synaptophysin
regulatori
peptid
use
antigen
demonstr
lung
includ
surfact
lysozym
immunoglobulin
microorgan
infect
lung
electron
microscopi
particularli
use
detail
character
injuri
cell
alveolar
epithelium
endothelium
figur
pulmonari
oedema
compon
mani
inflammatori
condit
lung
includ
induc
infecti
agent
howev
term
oedema
reserv
poorli
cellular
exud
character
presenc
pale
homogen
eosinophil
materi
alveoli
sometim
associ
similar
exud
lung
septa
perivascular
connect
tissu
occur
number
spontan
condit
congest
cardiac
failur
metastat
pulmonari
neoplasm
agon
chang
associ
pulmonari
congest
haemorrhag
drug
may
induc
cardiogen
pulmonari
oedema
consequ
pulmonari
hypertens
impair
ventricular
contractil
cardiogen
oedema
often
associ
vascular
congest
red
blood
cell
haemoglobin
may
leak
airspac
give
rise
presenc
haemoglobin
crystal
within
oedema
fluid
formalinfix
tissu
section
importantli
pulmonari
oedema
may
manifest
acut
lung
injuri
inhal
system
administr
toxic
chemic
may
produc
acut
pulmonari
oedema
see
figur
substanc
phenylthiourea
anaphlythiourea
produc
massiv
pulmonari
oedema
laboratori
anim
administ
oral
princip
result
damag
endothelium
pulmonari
capillari
venul
drug
report
produc
noncardiogen
pulmonari
oedema
human
either
directli
poorli
understood
immunogen
mechan
anoth
form
pulmonari
oedema
involv
main
airway
allerg
reaction
sensit
airway
asthmat
individu
believ
result
crosslink
ige
activ
mast
cell
degranul
releas
inflammatori
mediat
reproduc
main
airway
rat
sensit
ovalbumin
challeng
ovalbumin
intratrach
rout
treatment
lead
rapid
accumul
bronchial
exud
degranul
mast
cell
develop
mucos
oedema
mark
immedi
respiratori
epithelium
congest
haemorrhag
frequent
find
lung
laboratori
anim
usual
relat
certain
mode
death
associ
administr
drug
chemic
advers
effect
cardiac
function
coagul
system
administr
heparin
rat
produc
characterist
extravas
blood
air
space
lower
respiratori
tract
infect
gener
major
health
hazard
among
laboratori
anim
nevertheless
everpres
threat
caus
overt
respiratori
diseas
within
coloni
develop
follow
administr
xenobiot
subclin
pulmonari
infect
infest
also
produc
histolog
alter
bronchial
airway
pulmonari
parenchyma
mimic
chang
induc
inhal
irrit
system
administ
drug
furthermor
respiratori
pathogen
alter
immun
defenc
exacerb
effect
inhal
substanc
rang
bacteri
viral
pathogen
may
produc
inflammatori
lung
chang
typic
bacteri
pathogen
steptococcu
pneumonia
produc
acut
bronchiti
associ
variabl
degre
acut
inflamm
lung
parenchyma
bronchopneumonia
confluent
lobar
pneumonia
viral
agent
gener
associ
histolog
featur
bronchiol
interstiti
pneumonia
character
increas
mononuclear
cell
respiratori
bronchiol
alveolar
septa
histolog
featur
variabl
depend
particular
pathogen
speci
strain
immun
statu
presenc
absenc
secondari
infect
particular
stage
infect
examin
respiratori
infect
frequent
mix
chang
due
secondari
bacteri
infect
frequent
superimpos
induc
virus
sequenti
histopatholog
examin
lung
laboratori
anim
follow
inocul
respiratori
tract
pathogen
abl
character
evolut
patholog
chang
produc
individu
organ
instanc
follow
inocul
mycoplasma
pulmoni
one
import
respiratori
pathogen
among
laboratori
rodent
lewi
fischer
rat
shown
develop
upper
lower
respiratori
tract
inflamm
lewi
strain
character
day
variabl
acut
inflammatori
exud
bronchi
bronchiol
focal
bronchiectasi
inflamm
hyperplasia
epithelium
predominantli
macrophag
infiltr
alveoli
alveolar
wall
chang
associ
mark
hyperplasia
bronchusassoci
lymphoid
tissu
balt
extend
airway
blood
vessel
toward
peripheri
lung
although
lymphoid
hyperplasia
also
found
inocul
fischer
rat
less
mark
accompani
littl
mucopurul
exud
activ
inflamm
bronchial
wall
dispar
respons
suggest
differ
relat
degre
lymphocyt
activ
two
strain
imbal
regul
lymphocyt
prolifer
lewi
rat
studi
conduct
rat
mice
infect
anoth
import
respiratori
pathogen
laboratori
rodent
sendai
viru
parainfluenza
type
sequenti
studi
show
initi
damag
bronchial
bronchiolar
epithelium
associ
polymorphonuclear
lymphocyt
inflamm
bronchiol
immunocytochem
ultrastructur
studi
reveal
presenc
viral
antigen
mucosa
hyperplast
multinucl
syncyti
epitheli
cell
develop
hyperplast
termin
bronchiolar
epithelium
inflammatori
process
extend
involv
peribronchi
peribronchiolar
parenchyma
infiltr
alveolar
wall
mononuclear
cell
macrophag
neutrophil
similar
cell
popul
accompani
cell
debri
oedema
fluid
develop
air
space
pulmonari
arteri
show
minor
involv
inflammatori
cell
focal
reactiv
hyperplasia
endothelium
immunocytochemistri
ultrastructur
examin
suggest
viru
replic
take
place
alveolar
type
type
ii
epitheli
cell
macrophag
endotheli
interstiti
cell
alveolar
septa
shown
repair
occur
may
residu
distort
bronchiolar
alveolar
wall
collagen
hyperplast
cuboid
epithelium
may
line
thicken
alveolar
septa
air
space
may
also
contain
enlarg
macrophag
pale
vacuol
cytoplasm
strain
differ
suscept
also
demonstr
viru
differenti
pulmonari
interleukin
gene
express
virussuscept
brown
norway
rat
resist
fischer
rat
treatment
provid
protect
virusinduc
chronic
airway
inflamm
remodel
moreov
increas
tumour
necrosi
factor
tnfa
express
shown
import
regulatori
factor
develop
sendai
virusinduc
bronchiolar
flbrosi
infect
rat
virusinocul
brown
norway
rat
increas
tnfa
pulmonari
mrna
level
increas
number
bronchiolar
macrophag
fibroblast
express
tnfa
protein
compar
virusinocul
rat
corona
viru
caus
sialodacryoaden
mani
rat
coloni
also
produc
lower
respiratori
tract
inflamm
character
acut
bronchiti
bronchiol
focal
extens
lung
parenchyma
thicken
oedemat
hypercellular
alveolar
wall
infiltr
monocyt
cell
found
immunocytochemistri
shown
presenc
viral
antigen
bronchial
bronchiolar
epitheli
cell
also
peribronchi
lymphocyt
infiltr
increas
promin
balt
ultim
complet
resolut
occur
virus
remain
potenti
sourc
spontan
respiratori
diseas
laboratori
dog
canin
adenoviru
type
parainfiuenza
canin
herp
viru
coronaviru
parvoviru
isol
laboratori
dog
develop
respiratori
diseas
syndrom
viscer
larva
migran
also
incit
focal
inflamm
granuloma
fibrosi
lung
speci
dog
primat
parasit
preval
syndrom
viscer
larva
migran
usual
defin
result
migrat
nematod
larva
viscera
well
describ
beagl
dog
lung
result
larva
toxocara
speci
metastrongyloid
nematod
precis
identif
parasit
alway
possibl
tissu
section
histolog
appear
infest
lung
highli
variabl
nematod
surround
granuloma
granulomat
inflamm
mostli
subpleur
locat
may
visibl
section
affect
lung
may
perivascul
activ
arteriol
bronchiol
peribronchiol
pleural
involv
inflammatori
process
mark
particularli
region
overli
granuloma
scar
develop
pleural
subpleur
fibrosi
frequent
associ
epitheli
hyperplasia
squamou
metaplasia
associ
airway
figur
lesion
may
suffici
sever
resembl
induc
high
dose
anticanc
drug
bleomycin
see
pulmonari
acariasi
common
infest
mani
speci
nonhuman
primat
caus
variou
speci
mite
pneumonyssu
reproduct
mite
appear
take
place
termin
bronchiol
pneumonyssu
simicola
recogn
form
found
rhesu
monkey
although
preval
wild
caught
primat
diseas
easili
elimin
breed
captiv
even
elimin
ivemectin
lesion
chronic
bronchiol
bronchiectasi
pigment
may
persist
incident
find
mite
produc
signific
destruct
pulmonari
patholog
render
anim
suscept
secondari
pulmonari
bacteri
infect
disrupt
confound
interpret
toxic
studi
perform
primat
lesion
locat
frequent
cranial
lobe
character
presenc
bulla
distend
pleural
surfac
parenchym
cyst
nodul
scar
tissu
histolog
wide
rang
inflammatori
activ
fulli
develop
lesion
character
granulomat
bronchiol
peribronchiol
involv
immedi
adjac
alveoli
cystic
lesion
involv
bronchiolar
wall
develop
around
parasit
give
rise
appear
walledoff
cyst
compos
highli
cellular
granul
tissu
associ
neutrophil
lymphocyt
macrophag
multinucl
giant
cell
variou
pigment
see
less
activ
lesion
dilat
cystic
airway
wall
compos
thick
band
smooth
muscl
line
squamou
cuboid
epithelium
found
pneumocysti
carinii
import
caus
pneumonia
patient
acquir
immunodefici
syndrom
aid
well
immunocompromis
patient
includ
treat
immunosuppress
drug
natur
habitat
pneumocysti
carinii
pulmonari
alveoli
wide
encount
human
popul
without
associ
overt
diseas
clinic
experiment
evid
suggest
impair
cellular
immun
much
import
predispos
factor
impair
humor
immun
human
laboratori
anim
may
latent
pneumocysti
infect
becom
clinic
evid
follow
immunosuppress
shown
rat
chronic
administr
variou
regimen
adenocorticosteroid
low
protein
diet
cyclophosphamid
immunosuppress
drug
concomit
antibiot
administr
prevent
infect
give
rise
typic
pneumocysti
pneumonia
rodent
genet
defici
cellular
immun
also
develop
pneumocysti
pneumonia
import
pneumocysti
pneumonia
toxicolog
consid
sentinel
chronic
immun
depress
haematoxylin
eosin
stain
section
pneumocysti
pneumonia
character
human
rodent
presenc
alveoli
fill
foami
eosinophil
materi
contain
macrophag
indistinct
nuclei
pneumocysti
figur
ovoid
crescentshap
structur
organ
becom
clearli
visibl
gomori
methenamin
silver
toluidin
blue
stain
ultrastructur
studi
rat
pneumocysti
pneumonia
show
trophozoit
attach
frequent
type
pneumocyt
alter
morpholog
contour
pneumocyt
rather
process
invas
system
administ
therapeut
agent
may
produc
histolog
chang
within
lung
parenchyma
mimic
compon
normal
respons
respiratori
pathogen
howev
sharp
separ
agent
produc
pulmonari
oedema
associ
acut
inflammatori
chang
histolog
featur
overlap
acut
inflammatori
process
often
accompani
exud
within
airspac
exampl
druginduc
pulmonari
inflamm
laboratori
anim
human
report
follow
administr
interleukin
glycoprotein
lymphokin
molecular
weight
normal
produc
activ
cell
mediat
immunoregulatori
respons
produc
larg
quantiti
recombin
dna
technolog
use
tumour
immunotherapi
howev
high
dose
associ
number
advers
effect
notabl
vascular
leak
syndrom
character
clinic
pulmonari
oedema
pleural
effus
ascit
vascular
leak
syndrom
report
laboratori
anim
given
high
dose
agent
histolog
examin
lung
mice
develop
syndrom
follow
administr
show
infiltr
alveolar
wall
larg
lymphocyt
intraalveolar
proteinac
exud
contain
larg
lymphocyt
macrophag
red
blood
cell
pulmonari
venul
arteriol
show
presenc
lymphocyt
attach
lie
beneath
endothelium
infiltr
vessel
wall
perivascular
locat
accompani
oedema
fluid
red
blood
cell
similar
less
sever
chang
demonstr
rat
given
addit
treat
rat
show
infiltr
pulmonari
vasculatur
eosinophil
probabl
secondari
eosinopoiet
cytokin
produc
stimul
lymphocyt
immunocytochem
evalu
lymphoid
infiltr
mice
show
cell
thi
lymphocyt
furthermor
coadministr
asialo
gml
gangliontetrosylceremid
abrog
clinic
sign
also
reduc
number
asialo
gmlposit
lymphocyt
tissu
section
lymphoid
cell
express
cd
suppressorcytotox
cell
unaffect
asialo
gml
treatment
postul
vascular
leak
syndrom
antitumour
efficaci
mice
mediat
endogen
subset
stimul
lymphocyt
lymphokineactiv
killer
cell
correspond
chang
also
observ
liver
lymphoid
tissu
immunocytochem
detail
electron
microscop
studi
rat
support
concept
induc
cytotox
vascular
damag
mediat
directli
lymphokineactiv
killer
cell
cytotox
lymphocyt
secondari
releas
inflammatori
cytokin
human
sever
chronic
pulmonari
inflammatori
diseas
laboratori
anim
may
compromis
pulmonari
function
lead
secondari
alter
organ
although
mechan
explor
detail
diffus
interstiti
pulmonari
inflammatori
process
lung
haemorrhag
induc
rat
treat
two
year
prizidilol
skandf
antihypertens
agent
vasodil
adrenoceptor
block
properti
affect
anim
develop
dyspnoea
associ
reduct
lung
volum
deform
thorac
spinal
column
mark
cardiac
hypertrophi
inflamm
granuloma
develop
lung
laboratori
anim
varieti
differ
circumst
allud
common
caus
rodent
granulomat
pulmonari
inflamm
result
aspir
stomach
content
food
particl
aspir
pneumonia
sporad
observ
age
rodent
associ
gener
ill
health
particularli
result
pressur
effect
larg
pituitari
adenoma
subsequ
disturb
pharyng
laryng
reflex
mechan
histolog
lung
show
peribronchi
peribronchiolar
granulomat
inflamm
macrophag
foreign
bodi
cell
associ
fragment
refract
veget
matter
associ
bronchial
mucosa
may
also
show
reactiv
chang
includ
goblet
cell
hyperplasia
longstand
case
dog
primat
liabl
infest
parasit
granulomat
inflamm
respons
pulmonari
larva
common
speci
pulmonari
tuberculosi
repres
potenti
problem
among
nonhuman
primat
coloni
view
insidi
onset
liabil
transmiss
monkey
human
patholog
find
similar
well
known
human
diseas
diseas
character
presenc
granuloma
lung
parenchyma
lymph
node
florid
case
may
caseat
surround
epithelioid
multinucl
giant
cell
variabl
number
lymphocyt
plasma
cell
flbroblast
diffus
granulomat
pneumonia
result
tuberculosi
also
report
nonhuman
primat
granulomat
pneumon
also
produc
laboratori
anim
intraven
inject
bcg
twentyeight
day
follow
intraven
inject
bacil
calmetteguerin
bcg
lung
mice
contain
numer
granuloma
compos
histiocyt
round
cell
surround
alveoli
thicken
wall
associ
mild
interstiti
pneumon
histolog
chang
associ
increas
number
thi
cell
especi
cd
posit
lymphocyt
histolog
chang
abrog
treatment
cyclosporin
suggest
import
role
lymphocyt
develop
granuloma
discret
granuloma
occur
lung
experiment
anim
respons
intratrach
intraven
inject
certain
rel
insolubl
substanc
figur
intratrach
administr
insolubl
polymer
dextran
latex
microparticl
mice
show
morpholog
system
effect
granuloma
depend
natur
inject
substanc
shown
larg
granuloma
develop
rapidli
pulmonari
parenchyma
around
dextran
particl
subsequ
regress
quickli
wherea
latex
particl
produc
small
discret
stabl
granuloma
although
form
granuloma
foreign
bodi
nonimmunolog
type
produc
dextran
latex
bead
associ
anergylik
immunosuppress
probabl
caus
releas
solubl
factor
granuloma
report
granuloma
format
instil
sephadex
bead
associ
increas
interleukin
like
activ
lung
studi
compar
effect
inhal
crystallin
silica
titanium
dioxid
shown
correl
releas
macrophag
deriv
cytokin
granuloma
format
suggest
might
use
biomark
granuloma
format
local
angiocentr
granuloma
foreign
bodi
type
cluster
around
pulmonari
arteri
arteriol
occasion
alveolar
capillari
venul
also
develop
follow
intraven
inject
rel
insolubl
polysaccharid
polym
characterist
epithelioid
larg
foreign
bodi
type
giant
cell
effac
smaller
vessel
although
overt
necrosi
usual
observ
figur
haemosiderinladen
macrophag
accumul
alveou
laboratori
anim
associ
chronic
pulmonari
congest
haemorrhag
similar
chang
occur
patient
congest
cardiac
failur
haemosiderinladen
macrophag
term
heart
failur
cell
lung
nonhuman
primat
especi
liabl
contain
alveolar
perivascular
peribronchi
aggreg
macrophag
laden
variou
brown
pigment
ironcontain
pigment
associ
inflammatori
chang
produc
simian
lung
mite
pneumonyssu
simicola
preval
mani
nonhuman
primat
addit
lung
primat
coloni
may
show
perivascular
peribronchi
collect
browngrey
macrophag
contain
highli
refract
spicul
plate
compos
high
concentr
silica
shown
old
world
primat
includ
rhesu
cynomolgu
monkey
pigment
contain
fossil
diatomac
materi
compat
concept
anim
inhal
dust
contain
diatom
silicon
fragment
expos
semiarid
natur
habitat
chronic
lung
injuri
varieti
differ
caus
frequent
associ
develop
pulmonari
fibrosi
character
replac
normal
pulmonari
structur
thicken
collagen
matrix
consequ
reduct
capac
ga
exchang
regardless
incit
agent
fibrogen
process
appear
gener
character
disrupt
normal
alveolarcapillari
structur
leakag
exud
vascular
compart
airspac
subsequ
invas
infiammatori
cell
fibroblast
associ
excess
matrix
format
studi
laboratori
anim
differ
fibrogen
agent
well
human
suggest
central
pulmonari
fibrogenesi
increas
product
tnfa
macrophag
cytokin
mitogen
fibroblast
also
potent
activ
chemoattract
macrophag
capabl
stimul
releas
cytokin
induc
express
adhes
molecul
express
endotheli
cell
moreov
shown
tnfa
receptor
knockout
mice
appear
protect
fibroprolif
effect
inhal
asbesto
pulmonari
fibrosi
common
sequel
chronic
lower
respiratori
tract
inflamm
may
associ
preced
interstiti
pneumon
character
infiltr
lymphocyt
plasma
cell
macrophag
scatter
polymorphonuclear
cell
focal
pulmonari
fibrosi
occur
spontan
laboratori
anim
although
usual
preval
dog
nonhuman
primat
respons
chronic
infest
parasit
easili
elimin
breed
human
condit
lead
pulmonari
fibrosi
vari
wide
includ
infect
shock
lung
syndrom
ioniz
radiat
inhal
irrit
particul
matter
exposur
antigen
excess
amount
oxygen
well
result
toxic
paraquat
rang
cytotox
noncytotox
therapeut
agent
caus
pulmonari
parenchym
injuri
princip
therapeut
agent
produc
pulmonari
fibrosi
human
laboratori
anim
anticanc
drug
bleomycin
glycopeptid
prepar
deriv
streptomyc
verticillu
best
known
exampl
pulmonari
fibrosi
also
associ
clinic
use
number
anticanc
agent
includ
lnitrosourea
bcnu
carmustin
cyclophosphamid
busulphan
mitomycin
c
precis
mechan
involv
induct
pulmonari
fibrosi
antineoplast
drug
human
poorli
understood
true
incid
particular
drug
difficult
estim
confound
factor
cancer
patient
concomit
administr
sever
drug
radiat
oxygen
therapi
diffus
pulmonari
cancer
opportunist
infect
probabl
druginduc
fibrosi
accentu
concomit
administr
sever
antineoplast
agent
radiat
therapi
hyperoxia
preexist
pulmonari
damag
age
patient
sever
often
relat
total
dose
drug
receiv
novel
antineoplast
drug
may
also
produc
lung
toxic
bleomycin
associ
develop
interstiti
pneumonia
pulmonari
fibrosi
clinic
use
reproduc
experiment
anim
histopatholog
appear
bleomycininduc
pulmonari
fibrosi
patient
mani
instanc
differ
seen
laboratori
anim
lung
patient
treat
bleomycin
modifi
primari
neoplast
diseas
smoke
multipl
drug
radiat
therapi
secondari
pulmonari
infect
interstiti
pneumon
fibrosi
postul
tnfa
import
mediat
develop
bleomycininduc
fibrosi
preclin
evalu
bleomycin
beagl
dog
given
cycl
drug
intraven
rout
period
week
dog
develop
anorexia
weight
loss
varieti
epitheli
lesion
well
focal
interstiti
pneumonia
fibrosi
focal
lung
lesion
character
increas
elast
fibr
reticulin
collagen
acid
mucosubst
lesion
situat
predominantli
pleural
subpleur
zone
suggest
potenti
effect
friction
pleural
surfac
histolog
lesion
resembl
produc
larva
migran
dog
see
figur
similar
histolog
chang
also
describ
rat
mice
treat
bleomycin
intraven
intratrach
rout
fibrosi
consist
chang
bleomycintr
rodent
extens
employ
model
pulmonari
fibrosi
earli
chang
includ
mild
diffus
increas
interstiti
lymphocyt
macrophag
polymorphonuclear
cell
perivascular
interstiti
oedema
week
interstiti
infiltr
also
compris
fibroblast
earli
collagen
deposit
associ
prolifer
macrophag
type
ii
pneumocyt
subsequ
amount
interstiti
collagen
increas
eventu
scar
collaps
lung
tissu
proport
cumul
dose
given
immunohistochem
ultrastructur
studi
rat
mice
treat
bleomycin
show
larg
accumul
immunereact
laminin
redupl
basement
lamina
within
thicken
alveolar
wall
bleomycintr
rat
threedimension
scan
electron
microscopi
show
druginduc
capillari
remodel
compris
irregular
alveolar
pleural
capillari
increas
diamet
decreas
branch
certain
strain
mice
shown
possess
greater
sensit
bleomycin
fibrogenesi
strain
produc
greater
fibroblast
respons
swiss
mice
balbc
strain
demonstr
particularli
poor
fibroblast
respons
therapeut
use
cyclophosphamid
also
occasion
associ
develop
pulmonari
interstiti
fibrosi
appear
associ
two
form
patholog
earlyonset
pneumon
late
onset
progress
pulmonari
fibrosi
similar
chang
less
easi
reproduc
laboratori
anim
mice
sequenti
examin
period
one
year
singl
intraven
dose
loomgkg
cyclophosphamid
slight
pulmonari
interstiti
thicken
hypercellular
observ
associ
progress
multifoc
accumul
intraalveolar
macrophag
howev
chang
also
accompani
progress
increas
pulmonari
hydroxyprolin
content
decreas
pulmonari
complianc
time
treat
anim
compar
control
chang
amplifi
exposur
ambient
oxygen
bronchiol
alveolar
septal
infiamm
fibrosi
induc
gold
therapi
patient
rheumatoid
arthriti
probabl
immunemedi
condit
associ
peripher
eosinophilia
druginduc
alter
immun
system
emphysema
character
abnorm
perman
enlarg
airspac
distal
termin
bronchiol
accompani
destruct
wall
without
obviou
fibrosi
three
principl
type
centriacinar
panacinar
distal
acinar
emphysema
recogn
human
enlarg
air
space
result
congenit
factor
fibrou
scar
group
separ
regard
emphysema
emphysema
report
agerel
spontan
chang
laboratori
rat
howev
sever
experiment
rodent
emphysema
model
develop
use
intratrach
instil
proteolyt
enzym
papain
pancreat
neutrophil
elastas
give
rise
histolog
appear
resembl
panacinar
emphysema
human
irrit
gase
notabl
oxid
nitrogen
also
capabl
induc
chang
lung
laboratori
rat
hamster
follow
long
term
exposur
resembl
mild
human
centrilobular
emphysema
varieti
differ
name
appli
membranebound
acid
phosphataseposit
cytoplasm
inclus
lamella
crystalloid
ultrastructur
matrix
includ
myeloid
bodi
myelinoid
bodi
myelin
figur
myelinosom
lysosom
inclus
seen
small
number
varieti
normal
cell
type
accumul
variou
organ
laboratori
anim
follow
administr
wide
varieti
drug
divers
therapeut
class
gener
accumul
lysosom
cytoplasm
bodi
gener
call
phospholipidosi
term
coin
describ
tissu
accumul
phospholipid
light
microscop
level
phospholipid
character
increas
number
foam
cell
airspac
exampl
druginduc
phospholipidosi
includ
anorect
drug
chlorphentermin
tricycl
antidepress
inhibitor
cholesterol
biosynthesi
triparanol
antihistamin
chlorcyclizin
analogu
select
oestrogen
receptor
antagonist
tamoxifen
chloroquin
cardiovascular
drug
amiodaron
perhexilin
mani
tissu
organ
may
develop
cytoplasm
inclus
includ
lymphoid
cell
liver
pancrea
endocrin
tissu
nervou
system
muscl
cell
eye
particularli
lung
aminoglycosid
antibiot
may
produc
lamin
phospholipid
inclus
renal
tubular
cell
imidazol
antifung
hepatocyt
see
liver
kidney
chapter
mani
drug
induc
phospholipidosi
usual
share
structur
featur
notabl
hydrophil
cation
side
chain
primari
secondari
tertiari
amin
hydrophob
region
usual
aromat
ring
ring
system
structur
pattern
render
molecul
amphiphil
drug
probabl
bind
polar
lipid
mean
electrostat
hydrophob
forc
lead
format
druglipid
complex
poorli
degrad
lysosom
enzym
accumul
cell
cytoplasm
form
inclus
describ
bind
coval
revers
depend
dissoci
rate
constant
particular
intracellular
condit
drug
concentr
achiev
predict
activ
base
molecular
structur
shown
reason
good
correl
abil
compound
produc
phospholipidosi
cultur
rat
periton
macrophag
recent
cell
base
system
propos
screen
phospholipidosi
howev
perform
less
well
predict
vivo
potenc
presum
differ
drug
disposit
blood
tissu
underlin
accumul
foami
macrophag
alveolar
space
may
also
spontan
chang
laboratori
anim
long
recogn
spontan
alter
age
rat
may
also
found
lung
tissu
distal
bronchial
lesion
imped
clearanc
mechan
contrast
druginduc
chang
spontan
lipidosi
character
accumul
alveolar
foam
cell
occur
sporad
older
rat
observ
control
treat
anim
druginduc
phospholipidosi
occur
within
period
sever
month
lung
control
anim
remain
fairli
free
foam
cell
accumul
lung
appear
especi
vulner
druginduc
phospholipidosi
possibl
macrophag
close
proxim
bloodborn
agent
phospholipidosi
also
clearli
visibl
microscop
alveoli
wherea
easili
overlook
organ
continu
uptak
phospholipidrich
surfact
materi
alveoli
macrophag
lead
excess
accumul
phospholipid
catabol
impair
fact
lung
commonli
affect
potenti
use
diagnost
featur
mani
organ
phospholipidosi
extrem
difficult
recogn
haematoxylin
eosin
stain
section
although
chang
lung
specif
druginduc
phospholipidosi
increas
number
lipidcontain
lung
macrophag
treat
anim
compar
control
rel
easi
detect
provid
simpl
way
pathologist
screen
effect
sever
gener
phospholipidosi
rat
lung
show
irregular
pale
grey
yellowish
patch
discolor
pleura
parenchyma
result
patchi
confluent
aggreg
larg
pale
foami
macrophag
may
free
lie
pack
alveoli
accompani
granular
extracellular
materi
abund
cytoplasm
show
vacuol
appear
fine
eosinophil
granul
sometim
visibl
nuclei
round
central
locat
structur
variabl
size
figur
multilamin
cell
also
occasion
seen
vacuol
cell
firmli
attach
alveolar
wall
probabl
pneumocyt
foami
cell
stain
typic
phospholipid
eg
acid
haematin
although
neutral
lipid
may
also
present
stain
oil
red
semithin
plasticembed
section
stain
toluidin
blue
allow
better
character
phospholipidosi
organ
includ
lung
macrophag
air
space
contain
unmistak
dens
dark
round
cytoplasm
inclus
variabl
size
mm
diamet
plasticembed
section
also
show
inclus
pulmonari
cell
includ
pneumocyt
attach
alveolar
wall
seen
discharg
alveolar
space
organ
affect
phospholipidosi
ultrastructur
examin
reveal
dens
multilamellar
membran
numer
heterogen
dens
bodi
lysosom
origin
figur
bodi
need
distinguish
membran
bodi
form
result
fixat
ultrastructur
studi
lipid
tend
leach
becom
hydrat
form
myelinoid
membran
glutaraldehyd
fixat
structur
subsequ
fix
osmium
give
rise
electrondens
membran
figur
outsid
insid
cell
particularli
mitochondria
may
mistaken
patholog
lesion
lamella
pattern
seen
phospholipidosi
may
simpl
altern
dens
clear
line
space
nm
complex
arrang
clear
dens
line
typic
crystalloid
inclus
hexagon
aggreg
tubular
subunit
seen
organ
usual
found
lung
signific
variou
form
uncertain
probabl
repres
variou
phase
phospholipid
exist
influenc
proport
lipid
present
electron
microscop
examin
reveal
pulmonari
macrophag
affect
chang
inclus
may
present
pneumocyt
type
ii
pulmonari
capillari
endotheli
cell
smooth
muscl
cell
bronchiolar
epithelium
occasion
neutrophil
chang
typic
still
visibl
sever
week
withdraw
treatment
offend
agent
although
extent
pulmonari
phospholipidosi
lung
vari
dosag
regimen
anim
speci
studi
chlorphentermin
amiodaron
indic
similar
cytolog
ultrastructur
chang
occur
laboratori
anim
speci
studi
includ
rat
mice
hamster
guinea
pig
rabbit
dog
safeti
assess
amphiphil
drug
imphcat
human
drug
induc
phosphohpidosi
laboratori
anim
novel
compound
continu
found
possess
properti
produc
phosphohpidosi
laboratori
anim
vari
degre
sever
although
drug
produc
phosphohpidosi
anim
studi
human
drug
produc
phosphohpidosi
anim
shown
capabl
induc
signific
phosphohpidosi
human
clinic
practic
agent
chloroquin
amiodaron
shown
produc
phosphohpidosi
patient
also
induc
cellular
damag
organ
howev
phenomenon
phosphohpidosi
phospholipid
packag
behind
lysosom
membran
may
causal
relat
cellular
damag
human
inde
weight
evid
suggest
druginduc
phosphohpidosi
per
se
adapt
phenomenon
function
deleteri
consequ
unless
excess
henc
find
phosphohpidosi
anim
studi
novel
drug
requir
care
assess
case
case
basi
respect
implic
safeti
human
exampl
issu
iodin
benzofuran
deriv
amiodaron
potent
antiarrhythm
drug
effect
ventricular
arrhythmia
lung
toxic
continu
problem
patient
treat
cardiac
arrhythmia
drug
phosphohpidosi
occur
wide
varieti
organ
laboratori
anim
treat
amiodaron
also
liver
peripher
nerv
cell
skin
lymphoid
cell
lung
patient
therapeut
dose
although
pulmonari
interstiti
fibrosi
occur
associ
phosphohpidosi
patient
amiodaroneinduc
phosphohpidosi
rodent
associ
pulmonari
fibrosi
signific
function
alter
sever
theori
propos
pulmonari
alveol
interstiti
fibrosi
human
weight
evid
date
suggest
accumul
lipidladen
histiocyt
causal
relat
alveol
pulmonari
fibrosi
inde
overal
littl
evid
mere
presenc
phosphohpidosi
deleteri
organ
cytotox
possibl
metabolit
desethylamiodaron
propos
immunemedi
mechan
postul
possibl
favour
bind
drug
compon
pulmonari
tissu
might
also
involv
free
radic
format
indirect
influenc
inflammatori
mechan
also
possibl
pulmonari
diseas
result
interact
sever
mechan
metabol
factor
uniqu
particular
patient
despit
undoubt
differ
tissu
speci
sensit
develop
phosphohpidosi
dose
drug
disposit
metabol
elimin
degre
tissu
exposur
drug
import
consider
safeti
assess
drug
produc
phosphohpidosi
laboratori
anim
although
phosphohpidosi
like
occur
high
dose
employ
toxic
studi
lower
therapeut
dose
use
patient
suggest
may
offset
faster
ehmin
drug
characterist
small
laboratori
anim
potenti
drug
accumul
critic
tissu
eye
heart
especi
import
drug
administ
long
period
time
particularli
tissueplasma
ratio
amphiphil
drug
may
exceed
follow
repeat
administr
consequ
although
phospholipidosi
may
function
consequ
implic
human
drug
induc
phospholipidosi
laboratori
anim
assess
case
case
basi
due
consider
mechan
drug
disposit
clinic
riskbenefit
analysi
import
underlin
similar
morpholog
chang
due
increas
presenc
phospholipid
lysosom
also
result
treatment
compound
cation
amphiphil
structur
mechan
includ
direct
indirect
inhibit
lysosom
enzym
activ
reenforc
need
understand
mechan
chemic
induc
increas
phospholipid
lung
laboratori
anim
exampl
shown
glycosaminoglycan
accumul
inherit
human
lysosom
disord
inhibit
lysosom
enzym
therebi
induc
lysosom
phospholipid
inclus
reflect
administr
high
dose
trypanocid
drug
suramin
rat
induc
intracellular
storag
glycosaminoglycan
associ
phospholipid
inclus
divers
organ
includ
lung
although
light
microscopi
clear
vacuol
typic
seen
electron
microscop
examin
show
presenc
clear
vacuol
contain
glycosaminoglycan
lamellar
phospholipid
inclus
similar
effect
seem
produc
rat
semisynthet
heparinlik
macromolecular
carbohydr
deriv
chemic
structur
similar
glycosaminoglycan
use
clinic
anticoagul
effect
interstiti
nephriti
anoth
exampl
induct
lysosom
inclus
lung
rat
dog
macrolid
antibiot
erythromycin
collect
foam
cell
describ
lung
lymphat
tissu
dog
rat
treat
high
oral
dose
foam
cell
lung
show
pattern
small
whorl
vacuol
similar
seen
drug
induc
phospholipidosi
vitro
studi
suggest
macrolid
antibiot
potenti
caus
phospholipidosi
biochem
studi
suggest
drug
bind
phosphatidylinositolcontain
liposom
inhibit
activ
lysosom
phospholipas
close
correl
number
cation
group
carri
drug
hook
review
agent
oxid
gase
insolubl
particl
includ
silica
also
increas
phospholipid
level
histolog
appear
phospholipidosi
lung
agent
inhibit
phospholipid
catabol
lung
give
rise
accumul
surfact
protein
surfact
lipoprotein
clinicopatholog
pictur
similar
pulmonari
alveolar
proteinosi
human
studi
human
shown
three
chnical
distinct
form
condit
occur
congenit
secondari
acquir
congenit
diseas
caus
divers
rang
mutat
gene
encod
surfact
protein
chain
receptor
granulocytemonocyt
coloni
stimul
factor
gmcsf
secondari
form
occur
associ
condit
function
impair
reduc
number
alveolar
macrophag
haematolog
cancer
follow
immun
suppress
inhal
silica
toxic
fume
acquir
idiopath
alveolar
proteinosi
account
case
per
person
enigma
recent
patient
risk
infect
particularli
nocardia
year
surviv
rate
appear
studi
transgen
mous
model
human
shown
autoantibodi
gmcsf
import
develop
acquir
form
diseas
antibodi
caus
defect
macrophag
function
impair
catabol
surfact
lipid
protein
context
interest
note
treatment
imatinib
tyrosin
kinas
inhibitor
bcrabl
tyrosin
kinas
constitut
express
philadelphia
chromosom
posit
myeloid
leukemia
associ
accumul
lamellar
inclus
pulmonari
macrophag
leukaemia
patient
although
might
result
primari
diseas
studi
mice
suggest
imatinib
mesyl
actual
inhibit
fibrogen
activ
transform
growth
factor
prevent
fibrosi
induc
bleomycin
variou
form
hyperplasia
found
airway
lung
laboratori
anim
mucos
surfac
bronchi
may
show
hyperplasia
goblet
cell
squamou
hyperplasia
metaplasia
cell
line
termin
bronchiol
alveolu
may
also
show
hyperplasia
squamou
metaplasia
standard
classif
character
chang
histolog
section
develop
use
rodent
studi
goblet
cell
hyperplasia
wellrecogn
respons
mucosa
conduct
airway
chronic
inflamm
inhal
irrit
substanc
cigarett
smoke
sulphur
dioxid
degre
goblet
cell
hyperplasia
dictat
sever
durat
irrit
inflammatori
process
florid
case
goblet
cell
hyperplasia
character
thicken
pseudostratif
tracheal
bronchial
mucosa
popul
tall
mucu
secret
cell
abund
pale
cytoplasm
addit
goblet
cell
extend
airway
normal
anim
mucu
may
fill
distend
airway
impact
alveoli
less
florid
case
simpl
increas
number
goblet
cell
may
found
without
structur
chang
goblet
cell
hyperplasia
line
epithelium
may
accompani
increas
size
underli
submucos
gland
clearli
demonstr
patient
chronic
bronchiti
rat
submucos
gland
normal
quit
promin
speci
differ
may
exist
airway
laboratori
anim
variabl
endow
goblet
cell
submucos
mucou
gland
normal
rat
goblet
cell
line
airway
either
mous
hamster
factor
control
alter
uncertain
long
suggest
increas
mitot
activ
well
cell
convers
probabl
metaplasia
serou
clara
cell
mucou
cell
involv
recent
shown
mice
sensit
ovalbumin
subject
singl
antigen
challeng
aerosol
clara
cell
proxim
airway
show
great
plastic
becom
mucinsecret
cell
pharmacolog
agent
induc
goblet
mucou
cell
hyperplasia
rat
given
six
daili
inject
isoprenalin
nonselect
receptor
agonist
show
doseand
timedepend
increas
number
size
alcian
blueposit
goblet
mucou
cell
well
serou
cell
tracheal
bronchial
mucosa
associ
increas
length
width
depth
submucos
gland
similar
chang
produc
pilocarpin
although
alcian
blueand
pasposit
cell
increas
number
follow
agent
suggest
pilocarpin
induc
acid
neutral
glycoprotein
secret
comparison
distribut
chang
rat
follow
isoprenalin
salbutamol
pilocarpin
tobacco
smoke
show
region
differ
distribut
chang
airway
isoprenalin
produc
greater
increas
secretori
cell
peripher
airway
tobacco
smoke
produc
greater
increas
mitot
activ
isoprenalin
pilocarpin
produc
diffus
chang
select
agonist
salbutamol
chang
induc
therapeut
agent
presum
result
pharmacolog
activ
sturgess
reid
show
chang
rat
accompani
hypertrophi
pancrea
submaxillari
parotid
salivari
gland
see
digest
system
chapter
unlik
rat
mous
hamster
appear
predispos
develop
minor
multifoc
epitheli
hyperplasia
tracheal
bronchial
mucosa
spontan
advanc
age
chang
flat
polypoid
natur
compos
clear
cell
goblet
cell
epithelium
bronchi
show
squamou
metaplasia
respons
chronic
irrit
injuri
character
three
layer
epitheli
cell
abund
eosinophil
cytoplasm
promin
cell
boundari
may
associ
degen
alter
mucosa
goblet
cell
hyperplasia
squamou
metaplasia
also
develop
alveolar
parenchyma
respons
prolong
damag
produc
larg
burden
inhal
irrit
insolubl
dust
metaplasia
also
character
presenc
sever
layer
flatten
epitheli
cell
show
squamou
differenti
term
pulmonari
keratin
cyst
recommend
pulmonari
cystic
lesion
line
nonneoplast
squamou
epithelium
without
excess
prolif
chang
hyperplasia
bronchioloalveolar
type
ii
cell
hyperplasia
hyperplasia
may
involv
line
epithelium
alveoli
bronchioli
form
hyperplasia
term
alveolar
hyperplasia
adenomatosi
alveolar
bronchiol
epitheli
occur
spontan
induc
infect
administr
irrit
xenobiot
rat
hamster
histolog
lesion
consist
local
unencapsul
foci
hyperchromat
regular
cuboid
columnar
cell
invest
airspac
without
appreci
distort
alveolar
wall
neuroendocrin
hyperplasia
well
describ
hamster
although
small
aggreg
neuroendocrin
cell
neuroepitheli
bodi
found
variou
level
bronchi
bronchioli
normal
hamster
administr
nitrosamin
produc
neuroendocrin
hyperplasia
hyperplast
lesion
recogniz
group
noncili
cuboid
oval
columnar
cell
locat
bronchial
bronchiolar
epithelium
contain
argyrophil
granul
show
immunoreact
corticotrophin
acth
neuronespecif
enolas
ultrastructur
examin
reveal
presenc
densecor
cytoplasm
granul
apud
type
prolif
chang
also
report
speci
includ
rat
human
hypox
condit
although
suggest
chang
might
result
increas
peptid
content
rather
cell
prolifer
frequent
diagnos
neoplasm
world
wide
lung
cancer
usual
caus
smoke
tobacco
bronchogen
squamou
carcinoma
gener
common
subtyp
north
america
incid
adenocarcinoma
exce
squamou
cell
tumour
reason
fulli
understood
aggress
subtyp
small
larg
cell
neuroendocrin
lung
cancer
defin
small
larg
tumour
cell
greater
ten
mitos
per
seem
seen
almost
exclus
heavi
cigarett
smoker
contrast
find
peopl
squamou
cell
lung
tumour
occasion
seen
aris
spontan
laboratori
anim
even
laboratori
anim
rat
mice
hamster
monkey
dog
expos
tobacco
smoke
long
period
high
dose
fail
develop
increas
lung
tumour
moreov
appear
good
experiment
model
neuroendocrin
lung
cancer
thu
particular
caution
merit
use
anim
model
predict
lung
tumorigen
potenti
inhal
substanc
far
common
primari
pulmonari
neoplasm
found
laboratori
rat
mice
hamster
adenoma
adenocarcinoma
appear
develop
bronchiolar
alveolar
epithelium
although
precis
histogenesi
somewhat
disput
although
spontan
squamou
neoplasm
uncommon
rodent
cystic
keratin
lesion
induc
rat
high
burden
particul
materi
lung
pleural
mesothelioma
mesenchym
neoplasm
also
occur
speci
uncommon
induc
rodent
miner
fibr
mesenchym
tumour
similar
histolog
featur
soft
tissu
mesothelioma
may
show
either
epitheli
mesenchym
differenti
rat
strain
alveolar
bronchiolar
neoplasm
occur
spontan
rel
small
number
morpholog
ident
neoplasia
induc
administr
chemic
carcinogen
common
classifi
bronchioloalveolar
adenoma
pulmonari
adenoma
bronchioloalveolar
carcinoma
nation
toxicolog
program
databas
control
fischer
rat
use
carcinogen
studi
indic
overal
percentag
less
anim
bronchioloalveolar
adenoma
less
bronchioloalveolar
carcinoma
howev
rang
bronchioloalveolar
adenoma
differ
studi
seri
histolog
bronchioloalveolar
tumour
mostli
small
discret
round
nodul
locat
lung
parenchyma
compos
fairli
uniform
cell
moder
hyperchromat
nuclei
arrang
solid
alveolar
tubular
papillari
mix
growth
pattern
usual
compress
surround
tissu
without
infiltr
metastat
spread
adenoma
although
loss
differenti
infiltr
spread
adjac
tissu
occur
adenocarcinoma
ultrastructur
studi
bronchiolaralveolar
neoplasia
fischer
rat
shown
presenc
osmiophil
lamel
inclus
bodi
similar
found
alveolar
type
ii
cell
therefor
suggest
neoplasm
deriv
cell
type
pulmonari
squamou
carcinoma
occur
uncommon
spontan
neoplasm
rat
larg
prolif
benign
cystic
lesion
found
lung
rat
follow
accumul
larg
amount
particul
matter
term
pulmonari
cystic
keratin
epithelioma
regard
benign
neoplasm
lesion
show
evid
tissu
invas
regard
pulmonari
squamou
cell
carcinoma
similar
lesion
occasion
report
spontan
lesion
analog
neoplasm
found
commonli
strain
laboratori
mice
use
carcinogen
bioassay
although
consider
variat
incid
report
common
strain
mice
observ
low
frequenc
month
age
incid
reach
nearli
month
age
fewer
signific
number
found
mice
although
consider
interlaboratori
variat
nation
toxicolog
program
databas
control
mice
use
carcinogen
studi
indic
overal
percentag
male
femal
bronchioloalveolar
adenoma
respect
bronchioloalveolar
carcinoma
howev
rang
bronchioloalveolar
tumour
vari
consider
studi
seri
even
laboratori
mice
hous
similar
condit
show
variat
incid
neoplasm
time
incid
lung
adenoma
adenocarcinoma
occur
cdi
mice
use
control
carcinogen
bioassay
laboratori
similar
condit
period
year
vari
male
femal
contrast
strain
mice
strain
show
low
predisposit
develop
lung
adenoma
although
mous
pulmonari
adenoma
adenocarcinoma
resembl
common
lung
tumour
human
strain
differ
exploit
studi
genet
suscept
resist
pulmonari
adenoma
carcinoma
histolog
pulmonari
tumour
type
mice
gener
small
sharpli
circumscrib
nodul
compos
fairli
uniform
close
pack
column
cuboid
columnar
cell
arrang
tubular
papillari
structur
scanti
fibrovascular
stroma
figur
may
less
well
differenti
cellular
pleomorph
show
intrabronchi
growth
invad
lung
parenchyma
produc
metastat
spread
histogenesi
mous
pulmonari
adenoma
adenocarcinoma
disput
basi
sequenti
light
electron
microscop
studi
pulmonari
adenoma
induc
baggwebst
swiss
mice
transplacent
exposur
ethylnitrosourea
suggest
develop
either
alveolar
type
ii
cell
clara
cell
care
stepwis
analysi
use
light
microscop
electron
microscop
examin
suggest
adenoma
divid
three
princip
group
compos
solid
growth
uniform
cuboid
cell
expand
margin
limit
alveolar
septa
alveolar
pattern
cell
contain
concentr
arrang
cytoplasm
lamellar
bodi
abund
larg
mitochondria
similar
mitochondria
found
alveolar
type
ii
cell
tubular
papillari
pattern
compos
cuboid
cell
show
histolog
ultrastructur
featur
clara
cell
differenti
howev
immunocytochem
studi
chemic
induc
spontan
pulmonari
neoplasia
balbc
strain
mice
shown
major
adenocarcinoma
includ
show
papillari
pattern
contain
surfact
apoprotein
typic
type
ii
antigen
suggest
neoplasm
show
alveolar
type
ii
differenti
howev
view
plastic
clara
cell
exclud
clara
cell
origin
tumour
immunocytochemistri
specif
clara
cell
secretori
protein
express
transgen
mous
model
lung
carcinoma
develop
clara
cell
shown
protein
lost
tumour
cell
progress
also
shown
strain
mice
proport
tumour
papillari
solidalveolar
growth
pattern
vari
induc
agent
also
suggest
biolog
differ
exist
histolog
subtyp
squamou
carcinoma
report
seri
mous
studi
chemic
induc
mous
model
squamou
cell
carcinoma
gener
administr
nnitrosotrischloroethylurea
strain
differ
suscept
squamou
cancer
develop
demonstr
model
nih
swiss
aj
swrj
highli
suscept
akrj
resist
fvbj
balbcj
mice
show
intermedi
respons
carcinogen
high
incid
inher
variabihti
pulmonari
adenoma
adenocarcinoma
convent
mous
carcinogen
bioassay
sometim
give
rise
statist
signific
differ
control
treatment
group
consider
risk
overinterpret
group
differ
convent
mous
bioassay
analysi
group
differ
consider
need
given
tissu
sampl
procedur
agestandard
histor
control
incid
effect
food
intak
well
result
mutagen
studi
carcinogen
bioassay
rodent
speci
inde
consider
number
wide
employ
therapeut
agent
differ
class
produc
increas
benign
malign
pulmonari
tumour
carcinogen
studi
perform
mice
without
prove
signific
human
davi
monro
count
least
drug
type
physician
desk
refer
unit
state
instanc
carcinogen
bioassay
cfl
mice
treat
week
synthet
analges
tilidin
fumar
statist
signific
differ
p
report
incid
lung
adenocarcinoma
top
dose
femal
group
concurr
control
argu
group
differ
indic
tumorigen
potenti
tilidin
fumar
basi
incid
high
dose
group
within
histor
control
rang
tumorigen
effect
parallel
week
rat
carcinogen
studi
difficult
evalu
concern
metronidazol
nitroimidazol
import
therapeut
agent
activ
anaerob
organ
trichomona
speci
administr
compound
led
increas
incid
pulmonari
adenoma
carcinoma
three
separ
mous
carcinogen
bioassay
analysi
find
somewhat
complic
evid
metronidazol
show
mutagen
activ
bacteri
assay
use
strain
salmonella
typhimurium
argu
risk
human
patient
slight
increas
preval
pulmonari
tumour
like
result
chang
nutrit
statu
mice
effect
metronidazol
gut
fiora
similar
differ
could
occur
ad
libitum
fed
mice
fed
restrict
diet
also
postul
posit
find
bacteri
mutagenesi
assay
inher
part
antibacteri
activ
metronidazol
result
nitroreduct
occur
normal
mammalian
tissu
conclus
support
neg
effect
hamster
carcinogen
bioassay
well
lack
excess
cancer
risk
women
follow
year
common
occurr
lung
adenoma
strain
mice
util
develop
quantit
bioassay
carcinogen
activ
follow
demonstr
administr
carcinogen
strain
could
significantli
increas
incid
pulmonari
adenoma
within
period
six
month
mani
year
strain
mous
pulmonari
tumour
assay
use
test
larg
number
chemic
differ
class
includ
polycycl
hydrocarbon
nitrosamin
food
addit
alkyl
halid
metal
chemotherapeut
agent
howev
mani
test
system
correl
result
strain
test
year
carcinogen
studi
data
genotox
result
shown
poor
prudenc
need
use
test
hamster
develop
lung
adenoma
spontan
small
number
advanc
age
compos
uniform
cylindr
cell
similar
found
bronchial
epithelium
goblet
cell
show
distinct
mucu
product
immunohistochem
studi
similar
pulmonari
neoplasm
induc
hamster
nnitrosodiethylamin
show
presenc
clara
cell
antigen
earli
phase
develop
tumour
develop
becam
squamou
type
show
immunoreact
cytokeratin
clara
cell
origin
suggest
neoplasm
